[HTML][HTML] Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials
M Cozzolino, A Vitagliano, GN Cecchino, G Ambrosini… - Fertility and …, 2019 - Elsevier
Objective To evaluate the effectiveness of corifollitropin alfa in improving the success of IVF.
Design Systematic review and meta-analysis. Setting Not applicable. Patient (s) Infertile …
Design Systematic review and meta-analysis. Setting Not applicable. Patient (s) Infertile …
Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
Background In vitro maturation (IVM) has some advantages over conventional in vitro
fertilization (IVF), particularly in polycystic ovary syndrome (PCOS) where the risk of ovarian …
fertilization (IVF), particularly in polycystic ovary syndrome (PCOS) where the risk of ovarian …
Current options to lower the cost of in vitro fertilization: a comprehensive review
A Gardner, KL Smith, E Huuki, J Luizzi, DD Gunn… - F&S Reviews, 2023 - Elsevier
Although the first successful in vitro fertilization (IVF) cycle occurred over 40 years ago, the
financial cost of IVF remains steep and prevents several patients from pursuing this option …
financial cost of IVF remains steep and prevents several patients from pursuing this option …
Could the age difference of a single calendar year between patients undergoing IVF at 34, 35 or at 36 years old affect the IVF outcome? A retrospective data analysis
K Pantos, K Sfakianoudis, S Grigoriadis, E Maziotis… - Medicina, 2020 - mdpi.com
Background and Objectives: Clinicians are called to overcome age-related challenges in
decision making during In Vitro Fertilization (IVF) treatment. The aim of this study was to …
decision making during In Vitro Fertilization (IVF) treatment. The aim of this study was to …
[HTML][HTML] Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
This cost-effectiveness analysis was conducted from the patient's perspective alongside a
randomized controlled trial comparing corifollitropin alfa with follitropin beta for a single …
randomized controlled trial comparing corifollitropin alfa with follitropin beta for a single …
Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art
BR Carvalho - Revista Brasileira de Ginecologia e Obstetrícia, 2023 - SciELO Brasil
Physical and emotional burdens during the journey of infertile people through assisted
reproductive technologies are sufficient to justify the efforts in developing patient-friendly …
reproductive technologies are sufficient to justify the efforts in developing patient-friendly …
False allegations cannot go unchallenged: an appeal to shield researchers from dubious methods and ambiguous motives
M Fawzy - 2022 - osf.io
Before launching an investigation or releasing allegations, researchers, journals, and the
public should seek advice from statisticians and epidemiologists who do not work directly or …
public should seek advice from statisticians and epidemiologists who do not work directly or …
Corifollitropin Alfa Compared to Daily Recombinant FSH in in Vitro Fertilization Programmes: A Meta-Analysis of Randomized-Controlled Trials
MC Budani, S Fensore, M Di Marzio… - Clinical and …, 2023 - ricerca.unich.it
Background: Corifollitropin alfa (CFA) is a long-acting recombinant follicle-stimulating
hormone (rFSH) used for controlled ovarian stimulation (COS). Several studies analyzing …
hormone (rFSH) used for controlled ovarian stimulation (COS). Several studies analyzing …